The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Ras-related GTPase RhoB Represses NF-κB Signaling
Abstract
rhoB encoding a Ras-related GTPase is immediate-early inducible by genotoxic treatments, indicating that it is part of the cellular stress response. Here, we investigated the influence of RhoB on signal pathways that are rapidly evoked by genotoxic compounds. The data obtained show that wild-type RhoB neither affects activation of mitogen-activated protein kinases nor AP-1-dependent gene expression. However, RhoB inhibited both basal and genotoxic agent-stimulated activity of the transcription factor nuclear factor kappaB (NF-kappaB). Thus, RhoB attenuated alkylation-induced increase in the DNA binding activity of NF-kappaB and abrogated NF-kappaB-driven gene expression. Furthermore, RhoB inhibited decrease in the cellular amount of IkappaBalpha after genotoxic stress as well as after tumor necrosis factor alpha and 12-O-tetradecanoylphorbol acetate treatment. This indicates that RhoB represses NF-kappaB activation by inhibiting dissociation and subsequent degradation of IkappaBalpha. On the basis of the data, we suggest that RhoB is a novel negative regulator of NF-kappaB signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, RhoH and at least three other known Rho GTPases, RhoB (16), RhoD, and RhoE, constitute a category of Rho GTPases having functional effects opposite or antagonistic to those of other Rho GTPases, such as RhoA, Rac, and CDC42.”
From The Hematopoiesis-Specific GTP-Binding Protein RhoH Is GTPase Deficient and Modulates Activities of Other Rho GTPases by an Inhibitory Function (2002) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rho GTPases and the Actin Cytoskeleton
Hall, A. (1998) · Science · doi:10.1126/science.279.5350.509 · Cited by 6,193
THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
Baldwin, A. S. (1996) · Annual Review of Immunology · doi:10.1146/annurev.immunol.14.1.649 · Cited by 4,979
Ridley, A. J., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90163-7 · Cited by 4,468
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling
Ridley, A. J., Paterson, H. F., Johnston, C. L., Diekmann, D., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90164-8 · Cited by 3,616
An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047
TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,590
Suppression of TNF-α-Induced Apoptosis by NF-κB
Antwerp, D. J. V., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,558
Minden, A., Lin, A., Claret, F.-X., Abo, A., & Karin, M. (1995) · Cell · doi:10.1016/s0092-8674(05)80019-4 · Cited by 1,481
The small GTP-binding proteins Rac1 and Cdc42regulate the activity of the JNK/SAPK signaling pathway
Coso, O. A., Chiariello, M., Yu, J.-C., Teramoto, H., Crespo, P., Xu, N., Miki, T., & Silvio Gutkind, J. (1995) · Cell · doi:10.1016/s0092-8674(05)80018-2 · Cited by 1,397
An Essential Role for Rho, Rac, and Cdc42 GTPases in Cell Cycle Progression Through G 1
Olson, M. F., Ashworth, A., & Hall, A. (1995) · Science · doi:10.1126/science.7652575 · Cited by 1,146
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
An essential role for Rac in Ras transformation
Qiu, R., Chen, J., Kirn, D. H., McCormick, F. P., & Symons, M. H. (1995) · Nature · doi:10.1038/374457a0 · Cited by 882
Angel, P., Baumann, I., Stein, B., Delius, H., Rahmsdorf, H. J., & Herrlich, P. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.6.2256 · Cited by 694
Tyrosine Phosphorylation of IκB-α Activates NF-κB without Proteolytic Degradation of IκB-α
Imbert, V., Rupec, R. A., Livolsi, A., Pahl, H. L., Traenckner, E. B.-M., Mueller‐Dieckmann, C., Farahifar, D., Rossi, B., Auberger, P., Baeuerle, P. A., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)80153-1 · Cited by 647
Zhang, S., Han, J., Sells, M. A., Chernoff, J., Knaus, U. G., Ulevitch, R. J., & Bokoch, G. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.23934 · Cited by 614
Lamarche, N., Tapon, N., Stowers, L., Burbelo, P. D., Aspenström, P., Bridges, T., Chant, J., & Hall, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81371-9 · Cited by 572
Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins
Perona, R., Montaner, S., Saniger, L., Sánchez-Pérez, I., Bravo, R., & Lacal, J. C. (1997) · Genes & Development · doi:10.1101/gad.11.4.463 · Cited by 519
Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic
Gibbs, J. B., Oliff, A., & Kohl, N. E. (1994) · Cell · doi:10.1016/0092-8674(94)90308-5 · Cited by 517
Westwick, J. K., Lambert, Q. T., Clark, G. J., Symons, M. H., Aelst, L. V., Pestell, R. G., & Der, C. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1324 · Cited by 436
Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms
Li, N., & Karin, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13012 · Cited by 428
Intracellular localization of the P21rho proteins.
Adamson, P., Paterson, H. F., & Hall, A. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.119.3.617 · Cited by 387
van Dam, H., Duyndam, M., Rottier, R., Bosch, A., de Vries‐Smits, L., Herrlich, P., Zantema, A., Angel, P., & van der Eb, A. J. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05680.x · Cited by 375
Post-translational modifications of p21rho proteins.
Adamson, P., Marshall, C. J., Hall, A., & Tilbrook, P. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88661-1 · Cited by 335
Activation of NF-κB by Antineoplastic Agents
Das, K. C., & White, C. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14914 · Cited by 269
Critical role of Rho in cell transformation by oncogenic Ras.
Prendergast, G. C., Khosravi‐Far, R., Solski, P. A., Kurzawa, H., Lebowitz, P. F., & Der, C. J. (1995) · PubMed · Cited by 253
Montaner, S., Perona, R., Saniger, L., & Lacal, J. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12779 · Cited by 228
Sequential DNA damage‐independent and ‐dependent activation of NF‐κB by UV
Bender, K., Göttlicher, M., Whiteside, S. T., Rahmsdorf, H. J., & Herrlich, P. (1998) · The EMBO Journal · doi:10.1093/emboj/17.17.5170 · Cited by 221
Non-Ras targets of farnesyltransferase inhibitors: focus on Rho
Lebowitz, P. F., & Prendergast, G. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202175 · Cited by 212
Bergmann, M., Hart, L. A., Lindsay, M. A., Barnes, P. J., & Newton, R. C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6607 · Cited by 193
Molnár, Á., Theodoras, A. M., Zon, L. I., & Kyriakis, J. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13229 · Cited by 190
Jähner, D., & Hunter, T. R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.7.3682-3690.1991 · Cited by 175
Bacterial toxins that target Rho proteins.
Aktories, K. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119245 · Cited by 171
Canman, C. E., & Kastan, M. B. (1996) · Nature · doi:10.1038/384213a0 · Cited by 164
Botulinum ADP‐ribosyltransferase C3
Aktories, K., Rösener, S., BLASCHKE, U., & Chhatwal, G. S. (1988) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1988.tb13908.x · Cited by 160
Fritz, G., Kaina, B., & Aktories, K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.25172 · Cited by 153
Self-citationRhoGDI-3 Is a New GDP Dissociation Inhibitor (GDI)
Zalcman, G., Closson, V., Camonis, J., Honoré, N., Rousseau-Merck, M.-F., Tavitian, A., & Olofsson, B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30366 · Cited by 122
PRK1 Is Targeted to Endosomes by the Small GTPase, RhoB
Mellor, H., Flynn, P., Nobes, C. D., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.9.4811 · Cited by 112
RhoB Is Stabilized by Transforming Growth Factor β and Antagonizes Transcriptional Activation
Engel, M. E., Datta, P. K., & Moses, H. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9921 · Cited by 102
Esteve, P., Embade, N., Perona, R., Jiménez, B., del Peso, L., León, J., Arends, M. J., Miki, T., & Lacal, J. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202082 · Cited by 95
The Small GTP-Binding Protein Rho Potentiates AP-1 Transcription in T Cells
Chang, J., Pratt, J. C., Sawasdikosol, S., Kapeller, R., & Burakoff, S. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.4986 · Cited by 89
Regulation of Ras-related RhoB protein expression during the cell cycle.
Zalcman, G., Closson, V., Linares‐Cruz, G., Lerebours, F., Honoré, N., Tavitian, A., & Olofsson, B. (1995) · PubMed · Cited by 85
Fritz, G., & Kaina, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30637 · Cited by 83
Self-citationJiménez, B., Arends, M. J., Esteve, P., Perona, R., Sánchez, R. J. B., y Cajal, S. R., Wyllie, A. H., & Lacal, J. C. (1995) · PubMed · Cited by 71
Fritz, G., & Kaina, B. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.3.1768 · Cited by 58
Self-citationRas-Related GTPase RhoB Forces Alkylation-Induced Apoptotic Cell Death
Fritz, G., & Kaina, B. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2211 · Cited by 54
Self-citationFarnesyltransferase inhibitors and anti-Ras therapy
Gibbs, W. W., Kohl, N. E., Koblan, K. S., Omer, C. A., Sepp‐Lorenzino, L., Rosen, N. X., Anthony, N. J., Conner, M. W., DeSolms, S. J., Williams, T. M., et al. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01803786 · Cited by 42
Functional interaction between RhoB and the transcription factor DB1
Lebowitz, P. F., & Prendergast, G. C. (1998) · Cell Communication & Adhesion · doi:10.3109/15419069809010787 · Cited by 35
Esteve, P., del Peso, L., & Lacal, J. C. (1995) · PubMed · Cited by 34
Baumann, B., Kistler, B., Kirillov, A., Bergman, Y., & Wirth, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.19.11448 · Cited by 25
Research works printed but not linked: 6
- Prendergast, 1995, Oncogene, 10, 2289
- Esteve, 1995, Oncogene, 11, 2657
- Jimenez, 1995, Oncogene, 10, 811
- Jähner, 1991, Mol. Cell. Biol., 11, 3682
- Zalcman, 1995, Oncogene, 10, 1935
- Angel, 1987, Mol. Cell. Biol., 7, 2256
Cited by
Role of resistant starch in improving gut health, adiposity, and insulin resistance
Keenan, M. J., Zhou, J., Hegsted, M., Pelkman, C., Durham, H. A., Coulon, D. B., & Martin, R. J. (2015) · Advances in Nutrition · doi:10.3945/an.114.007419 · Cited by 243
Li, X., Bu, X., Lu, B., Avraham, H., Flavell, R. A., & Lim, B. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.4.1158-1171.2002 · Cited by 153
Sato, N., Fukui, T., Taniguchi, T., Yokoyama, T., Kondo, M., Nagasaka, T., Goto, Y., Gao, W., Ueda, Y., Yokoi, K., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22328 · Cited by 56
miR-142-3p Regulates BDNF Expression in Activated Rodent Microglia Through Its Target CAMK2A
Gupta, N., Jadhav, S., Tan, K.-L., Saw, G., Mallilankaraman, K. B., & Dheen, S. T. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00132 · Cited by 40
Metadata
- Authors
- Fritz, G., & Kaina, B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 276
- Issue
- 5
- Pages
- 3115-3122
- ISSN
- 0021-9258
- Cited by
- 57
- References
- 49
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7193 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.